Corrigendum to 'Efficacy of emicizumab is maintained throughout dosing intervals for bleed prophylaxis' [Research and Practice in Thrombosis and Haemostasis, Volume 7, Issue 2, February 2023, 100077].
Res Pract Thromb Haemost
; 7(4): 100191, 2023 May.
Article
em En
| MEDLINE
| ID: mdl-37538504
ABSTRACT
[This corrects the article DOI 10.1016/j.rpth.2023.100077.].
Texto completo:
1
Base de dados:
MEDLINE
Idioma:
En
Ano de publicação:
2023
Tipo de documento:
Article